NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Cash and Bank History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Cash and Bank | ₹77 Cr | ₹38 Cr | ₹4.18 Cr | ₹2.48 Cr | ₹3.29 Cr |
What is the latest Cash and Bank ratio of NATH BIOGENES (INDIA) ?
Year | Cash and Bank |
---|---|
Mar2024 | ₹77 Cr |
Mar2023 | ₹38 Cr |
Mar2022 | ₹4.18 Cr |
Mar2013 | ₹2.48 Cr |
Mar2012 | ₹3.29 Cr |
How is Cash and Bank of NATH BIOGENES (INDIA) Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2024 | ₹77 Cr | 103.74 | |
Mar2023 | ₹38 Cr | 808.75 | |
Mar2022 | ₹4.18 Cr | 68.59 | |
Mar2013 | ₹2.48 Cr | -24.64 | |
Mar2012 | ₹3.29 Cr | - |
Compare Cash and Bank of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹280.6 Cr | -7.5% | -10.3% | -22.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹11,483.1 Cr | -8.2% | -17.5% | 0.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,362.5 Cr | -1.7% | 10.3% | 58.5% | Stock Analytics | |
VENKYS (INDIA) | ₹2,242.1 Cr | -3.7% | -5.5% | -8.3% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,348.4 Cr | -5.9% | -12.1% | -40.5% | Stock Analytics | |
INDO US BIOTECH | ₹328.8 Cr | -13.2% | -24.6% | -32.6% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -7.5% |
-10.3% |
-22.8% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses